Mangalam Organics Ltd (IN:MANORG)
:MANORG
Want to see IN:MANORG full AI Analyst Report?
Top Page
Mangalam Organics Ltd
(MANORG)
Select Model
Select Model
Rating:61Neutral
Price Target:
₹566.00
▲(16.64% Upside)
Action:Reiterated
Date:05/05/26
The score is held back mainly by weak profitability and deteriorating/negative cash flows despite revenue and margin improvement. Technicals are supportive with strong trend momentum, but overbought signals add risk. Valuation appears somewhat demanding with no dividend yield data to offset it.
Positive Factors
Improving Gross Margins
A large gross margin improvement to 48.40% signals stronger product mix and/or pricing power in terpene and camphor derivatives. Sustained higher gross margins support durable operating leverage and reinvestment capacity if raw-material spreads and product mix remain favorable.
Negative Factors
Weak Cash Generation
Operating cash flow turning negative and a steep decline in free cash flow severely constrain internal funding for capex, working capital and debt service. Unless cash conversion improves, the company may need external financing or cut investments, affecting long-term growth execution.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving Gross Margins
A large gross margin improvement to 48.40% signals stronger product mix and/or pricing power in terpene and camphor derivatives. Sustained higher gross margins support durable operating leverage and reinvestment capacity if raw-material spreads and product mix remain favorable.
Read all positive factors
Mangalam Organics Ltd (MANORG) vs. iShares MSCI India ETF (INDA)
Market Cap
₹5.02B
Dividend YieldN/A
Average Volume (3M)489.00
Price to Earnings (P/E)24.3
Beta (1Y)1.09
Revenue Growth27.49%
EPS Growth151.36%
CountryIN
Employees307
SectorBasic Materials
Sector Strength58
IndustryChemicals - Specialty
Share Statistics
EPS (TTM)28.28
Shares Outstanding8,564,440
10 Day Avg. Volume561
30 Day Avg. Volume489
Financial Highlights & Ratios
PEG Ratio0.14
Price to Book (P/B)1.08
Price to Sales (P/S)0.60
P/FCF Ratio-4.22
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Mangalam Organics Ltd Business Overview & Revenue Model
Company Description
Mangalam Organics Limited manufactures, supplies, and exports terpene chemicals and synthetic resins in India. It operates through Terpene Operations and Synthetic Resin Operations segment. The company offers terpene products, including camphor, c...
How the Company Makes Money
Mangalam Organics primarily makes money by manufacturing and selling specialty organic chemicals, with revenues largely driven by (1) camphor and camphor derivatives and (2) terpene chemicals/derivatives supplied to downstream consumer and industr...
Mangalam Organics Ltd Financial Statement Overview
Summary
Income Statement
65
Positive
Balance Sheet
58
Neutral
Cash Flow
52
Neutral
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 5.78B | 5.30B | 4.94B | 4.93B | 4.91B | 3.38B |
| Gross Profit | 2.59B | 2.57B | 1.13B | 701.20M | 1.47B | 1.72B |
| EBITDA | 783.42M | 589.13M | 390.38M | -24.27M | 924.25M | 1.28B |
| Net Income | 242.13M | 125.97M | 42.86M | -272.25M | 537.43M | 847.79M |
Balance Sheet | ||||||
| Total Assets | 7.29B | 6.24B | 4.85B | 5.06B | 5.60B | 3.11B |
| Cash, Cash Equivalents and Short-Term Investments | 411.72M | 189.27M | 20.19M | 12.79M | 12.78M | 343.55M |
| Total Debt | 3.52B | 2.72B | 1.73B | 1.90B | 2.12B | 243.11M |
| Total Liabilities | 4.21B | 3.30B | 2.05B | 2.30B | 2.56B | 596.26M |
| Stockholders Equity | 3.09B | 2.93B | 2.81B | 2.76B | 3.04B | 2.52B |
Cash Flow | ||||||
| Free Cash Flow | -769.42M | -751.15M | 327.48M | 361.57M | -1.84B | -27.60M |
| Operating Cash Flow | -281.34M | -78.44M | 727.23M | 769.23M | -841.04M | 262.79M |
| Investing Cash Flow | -381.05M | -670.47M | -395.09M | -407.80M | -995.25M | -281.47M |
| Financing Cash Flow | 673.44M | 736.26M | -325.52M | -355.77M | 1.83B | 22.66M |
Mangalam Organics Ltd Technical Analysis
Positive
485.25
Price Trends
466.03
Positive
458.77
Positive
488.66
Positive
Market Momentum
34.12
Positive
62.32
Neutral
27.68
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MANORG, the sentiment is Positive. The current price of 485.25 is below the 20-day moving average (MA) of 544.71, above the 50-day MA of 466.03, and below the 200-day MA of 488.66, indicating a bullish trend. The MACD of 34.12 indicates Positive momentum. The RSI at 62.32 is Neutral, neither overbought nor oversold. The STOCH value of 27.68 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IN:MANORG.
Mangalam Organics Ltd Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹6.47B | 19.55 | ― | ― | 15.71% | -3.48% | |
64 Neutral | ₹28.69B | 11.40 | ― | 0.09% | 15.19% | 9.27% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ₹5.02B | 24.26 | ― | ― | 27.49% | 151.36% | |
60 Neutral | ₹6.57B | 22.24 | ― | 1.23% | -5.04% | -26.70% | |
54 Neutral | ₹3.25B | 22.01 | ― | 0.25% | 30.35% | -15.12% | |
52 Neutral | ₹7.58B | 101.17 | ― | 1.07% | -14.55% | -74.70% |
* Basic Materials Sector Average
IN:MANORG
Mangalam Organics Ltd
570.00
4.70
0.83%
IN:AARTISURF
Aarti Surfactants Ltd.
383.25
-199.11
-34.19%
IN:CHEMCON
Chemcon Speciality Chemicals Ltd
183.95
-13.35
-6.77%
IN:FAIRCHEMOR
Fairchem Organics Ltd
614.95
-218.12
-26.18%
IN:JAYAGROGN
Jayant Agro-Organics Limited
231.20
-27.86
-10.75%
IN:ROSSARI
Rossari Biotech Ltd
526.85
-132.45
-20.09%
Mangalam Organics Ltd Corporate Events
CRISIL Reaffirms Mangalam Organics’ Rs 397-Crore Bank Facility Ratings on Watch
Apr 14, 2026
Mangalam Organics Ltd has announced that CRISIL Ratings has reviewed and reaffirmed the company’s credit ratings on its bank facilities totaling Rs. 397 crore. The long-term rating remains at CRISIL BBB+ and the short-term rating at CRISIL A...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.